Contract 75N91021F00002

The Univeristy Of Texas M.D. Anderson Cancer Center · Department Of Health And Human Services · September 2, 2021

Firm Fixed PriceFull & Open CompetitionNAICS 541714IDIQ Task Order

The Univeristy Of Texas M.D. Anderson Cancer Center was awarded a federal contract by Department Of Health And Human Services (National Institutes Of Health) on September 2, 2021 for $4.81 million of work in research and development in biotechnology (except nanobiotechnology). Performance is in Houston, TX. This is a task or delivery order issued under parent IDIQ 75N91019D00021. It was awarded under full and open competition. The contract has been modified 16 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on November 20, 2025.

Obligated to date
$4.81M
$4,809,888
Current value
$930.2K
Modifications
16
Latest November 20, 2025

Contract details

PIID
75N91021F00002
Parent IDIQ
75N91019D00021
Award type
Delivery Order
Pricing
Firm Fixed Price
Set-aside
No Set Aside Used.
Competition
Full And Open Competition
NAICS
541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
Product / service
Health R&D Services; Health Care Services; Applied Research
Place of performance
Houston, TX
First action
September 2, 2021
Latest action
November 20, 2025

Description

BASE CONTRACT TITLE: PREVENT PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY & INTERMEDIATE BIOMARKERS TASK ORDER TITLE: TARGETING STAT3 TO PREVENT COLORECTAL CANCER SECONDARY TO INFLAMMATORY BOWEL DISEASE

Modification timeline

  • November 20, 2025
    Mod P00007 · Supplemental Agreement For Work Within Scope
    $930.2K
  • September 23, 2025
    Mod P00008 · Change Order
    1) DESCOPE SOW FOR TERM OPT PD 4, DECREASE ITS NEGOTIATED COST AND THE CONTRACT TOTAL DUE TO EOI:: IMPLEMENTING THE PRESIDENTS DEPART OF GOVERNMENT EFFICIENCY COST EFFICIENCY INITIATIVE (MARCH 19, 202…
    $1.63M
  • August 4, 2025
    Mod P00004 · Supplemental Agreement For Work Within Scope
    PROJECT TITLE: FURTHER EVALUATION OF AMHR2-ED ANTIGENS FOR EPITHELIAL OVARIAN CARCINOMA
    $1.03M
  • June 30, 2025
    Mod P00010 · Terminate For Convenience (Complete Or Partial)
    EOI:: IMPLEMENTING THE PRESIDENTS DEPARTMENT OF GOVERNMENT EFFICIENCY COST EFFICIENCY INITIATIVE (MARCH 19, 2025)::
    $6.29M
  • June 27, 2025
    Mod P00007 · Exercise An Option
    VIRTUAL POOLED REGISTRY (VPR) PROJECT
    $1.63M
  • September 19, 2024
    Mod P00006 · Supplemental Agreement For Work Within Scope
    THIS MODIFICATION INCREASES THE TASK ORDER VALUE AND EXTENDS THE PERIOD OF PERFORMANCE.
    $6.26M
  • August 21, 2024
    Mod P00005 · Supplemental Agreement For Work Within Scope
    $932.9K
  • June 25, 2024
    Mod P00005 · Exercise An Option
    VIRTUAL POOLED REGISTRY (VPR) PROJECT
    $1.30M
  • September 27, 2023
    Mod P00003 · Other Administrative Action
    THIS MODIFICATION INCREASES THE TASK ORDER VALUE AND EXTENDS THE PERIOD OF PERFORMANCE.
    $6.26M
  • September 23, 2021
    Base award
    STERLING COMPUTERS:1110316 [21-059151] TO PURCHASE POWEREDGE R650 SERVER AND DELL DIGITAL KVM SWITCH
    $23.0K

Similar contracts

RecipientAgencyDateObligated
Vericel CorporationDepartment Of Health And Human ServicesApril 1, 2026$34.88M
Pattern Bioscience, Inc.Department Of Health And Human ServicesMarch 31, 2026$22.50M
Ceramedix Holding, LlcDepartment Of Health And Human ServicesMarch 31, 2026$4.22M
Glaxosmithkline, LlcDepartment Of Health And Human ServicesMarch 31, 2026$7.79M
American College Of Medical Toxicology, Inc.Department Of Health And Human ServicesMarch 31, 2026$0
Care Access Research LlcDepartment Of Health And Human ServicesMarch 31, 2026$2.55M

Top contractors in NAICS 541714

Lifetime obligated dollars across all federal contracts in this NAICS code.

#ContractorContractsObligated
1Amgen USA Inc1$59.99M
2Vericel Corporation1$34.88M
3Spectral Md, Inc.1$31.67M
4Ppd Development Lp6$31.12M
5L3 Technologies, Inc.1$22.00M
6Technical Resources International, Inc.6$21.80M
7Abbott Laboratories1$21.01M
8Paratek Pharmaceuticals, Inc1$17.47M
9Ossium Health, Inc.1$12.39M
10Rho Federal Systems Division Inc1$8.00M

Track this on BesaGov

Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.

✓ You’re on the list. We’ll never spam you.

Helpful guides

Continue learning

See all guides →
More on BesaGov

Keep researching

Track this contract, set alerts on similar opportunities, and build proposal pipelines on BesaGov.
Sign up free

Frequently asked questions

What is contract 75N91021F00002?

Contract 75N91021F00002 is a federal contract awarded to The Univeristy Of Texas M.D. Anderson Cancer Center by Department Of Health And Human Services on September 2, 2021 for $4.81 million of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 16 times since the base award.

Who won contract 75N91021F00002?

The Univeristy Of Texas M.D. Anderson Cancer Center won contract 75N91021F00002 from Department Of Health And Human Services.

How much is contract 75N91021F00002 worth?

Contract 75N91021F00002 has obligated $4.81 million to date.